WHAT IF WE COULD PUT THE POWER TO PREVENT HIV IN WOMEN’S HANDS?
In some countries, women are up to six times more likely to contract HIV than men. We are developing groundbreaking therapies for STDs—including new ways for women to protect themselves from HIV.
We are pioneering woman-controlled HIV preventionWatch Video
Spotlight on: STDs
15 million new cases of sexually transmitted infections are diagnosed each year in the U.S.
Untreated STDs cause infertility in 24,000 women every year, and many can be passed to babies, including:
- Genital herpes
WHAT MAGEE SCIENTISTS ARE DOING
- We are developing new therapies to treat, prevent, and cure diseases affecting women and their communities.
- We are developing new therapies for STDs, including HIV prevention products for the world’s most vulnerable populations.
- We are developing new techniques to treat STDs that cause infertility and pregnancy complications.
- We are helping adolescents, pregnant women, and postmenopausal women with our research on infections that are common among these groups.
Clinical Research & Trials
For over two decades, we have dedicated our clinical research studies and clinical trials to improving the health care of women, men, and infants everywhere. Our research would not be possible without the generous participation of many study volunteers.Learn More
Dr. Sharon Achilles’ research aims to address the knowledge gap that rests at the intersection between HIV prevention and family planning. Dr. Achilles’ longstanding research and clinical interests include contraception, microbicides, and the prevention of reproductive infectious disease.
The focus of Dr. Lisa Rohan’s laboratory lies in the area of drug delivery and targeting systems. Dr. Rohan concentrates on the design of drug delivery systems that can be applied to the areas of infectious disease, irritable bowel syndrome, and women’s cancers.